Role of the calcium-sensing receptor in parathyroid gland physiology

Role of the calcium-sensing receptor in parathyroid gland physiology

Randolph A. Chen and William G. Goodman

The calcium-sensing receptor (CaSR) represents the molecular mechanism by which parathyroid cells detect changes in blood ionized calcium concentration and modulate parathyroid hormone (PTH) secretion to maintain serum calcium levels within a narrow physiological range. Much has been learned in recent years about the diversity of signal transduction through the CaSR and the various factors that affect receptor expression. Beyond its classic role as a determinant of calcium-regulated PTH secretion, signaling through the CaSR also influences both gene transcription and cell proliferation in parathyroid cells. The CaSR thus serves a broad physiological role by integrating several distinct aspects of parathyroid gland function. The current review summarizes recent developments that enhance our understanding of the CaSR and its fundamental importance in parathyroid gland physiology.

Author pronuvia

Pronuvia is dedicated to improving the lives of patients with ongoing clinical trials and research. We are also focused on lowering health care costs by developing simple but innovative and effective treatments. Bringing optimum health to general public affordably and painlessly is the grand ambition of Pronuvia. Our research continues.

This website is intended to inform and educate medical professionals. It is not intended for patients. It also does not seek to make claims about the effectiveness of SAC calcium in medical treatment.

Regulated calcium intake can have manifold health effects. Too much or too little calcium and even wrong types of calcium can affect our health negatively. Only ionic calcium plays important physiological functions in our body, and yet many people have chronic ionic calcium deficiency. This site serves to inform medical professionals about ionic calcium’s potential in treating calcium-related diseases by introducing numerous third-party researches done. However, ionic calcium treatment is still an evolving field, and clinical studies are still insufficient to determine its effectiveness.

SAC calcium’s higher solubility provides needed amount of ionic calcium to trigger calcium homeostasis. While Pronuvia’s SAC calcium has Canadian FDA registration (NPN 80043292) and is produced in a FDA compliant laboratory, it has not been approved as a therapeutic treatment.

Patients interested in SAC calcium therapy are advised to consult a participating physician to participate in a clinical trial.